On October 22, Eastern time, the US FDA officially approved Gilead’s antiviral Veklury (remdesivir) for use in adults 12 years and older and weighing at least 40 kg in need of hospitalization and COVID-19 treatment. According to the FDA, Veklury is currently the only FDA-approved COVID-19 t...
Read more